We use cookies for a better user experience. Read our Privacy Policy

I Agree

Viral Clearance Service Market

Viral Clearance Service Market (Application - Recombinant Proteins, Tissue and Blood Derived Products, Vaccines; Method - Viral Removal, Viral Inactivation (Chemical, Radiation); End user - Biopharmaceuticals, Contract Research Organizations, Academic Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Global Viral Clearance Service Market - Snapshot

The global viral clearance service market was valued at US$ 261.9 Mn in 2017 and is anticipated to reach US$ 902.1 Mn by 2026, expanding at a CAGR of 14.9% from 2018 to 2026. Increase in demand for detection of virus removal/inactivation in products during their early stages of development, rise in R&D expenditure, growing preference for outsourcing of viral clearance service to contract research organizations, rise in consumer awareness about safety associated with the use of health care and vaccines, and increase in concern of viral effects of blood-derived products are some factors boosting the demand for viral clearance service. Moreover, emergence of technologies, such as nanofilteration and chromatography services, and choice of choosing the method depends on type of product, process, and regulatory. The user would need to determine the level of virus clearance required (as per logarithmic reduction) before marketing approval of new molecules. Companies have started focusing on efficacy and quality with high investments in R&D owing to stringent restructuring of regulations by both U.S. FDA and the European Medicines Agency that have put in place requirements for viral safety in relation to biologics. This has ultimately helped boost the viral clearance service market.

The viral clearance service market is witnessing robust expansion owing to increasing complexity of clinical trials, greater number of regulatory hurdles, and high investment required for infrastructure that results in greater clinical trials cost. Consequently, rising number of pharmaceutical companies are partnering with viral clearance service providers having the requisite infrastructure and expertise to manage costs and deadlines. Moreover, increasing focus on specialty drugs is likely to fuel the market, as specialty drugs require scientific expertise and highly tailored clinical trials that significantly increase costs.

viral-clearance-service-market.jpg

The viral clearance service market has been segmented based on application, method, end-user, and region. In terms of applications, the recombinant proteins segment is estimated to account for a prominent share of the market. Rising prevalence of diseases, such as cardiovascular, diabetes, and oncological, robust pipeline of pharmaceutical and biopharmaceutical products, increasing expenditure on research and development, rising emphasis on innovative treatment therapies for existing as well upcoming diseases, increasing demand for outsourcing analytical testing, and optimal service provided by the viral clearance service provider companies are major factors driving the global viral clearance service market.

In terms of method, the global viral clearance services has been classified into viral removal and viral inactivation method. The viral removal segment leads the market and accounts for a major share, as it is a robust and effective method of removal of different types of viruses. It is also expensive, safe, and brings about a high degree of purity of sample. The viral inactivation segment has been further sub-segmented into chemical, radiation, and others such as pasteurization and dry and moist heat treatment.

In terms of end-user, the global viral clearance service market has been categorized into biopharmaceuticals, contract research organizations, academic research institutes and other end-users. The biopharmaceuticals segment held a major market share in 2017. This can be attributed to the rise in R&D expenditure of these industries, increased outsourcing of clinical studies to contract research organizations that enables them to manage R&D costs and focus on their core competencies, and increase in pressure from regulatory agencies for viral removal/inactivation process in order to prove product safety to obtain market approval.

In terms of region, the global viral clearance service market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global viral clearance services market due to the presence of a large number of viral clearance removal/inactivation service providers, high health care spending, and stringent regulations governing safety assessment of biologics and vaccines. Europe follows North America in terms of share of the market, which can be ascribed to the amendment of regulation made by governments in Europe in order to assess the safety of biological substances. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period owing to the emergence of CROs offering viral clearance services, as per regulatory requirements at a lower cost than that in other developed regions.

Prominent players operating in the global viral clearance service market include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA (BioReliance), WuXi AppTec, Clean Cells, and Vironova Biosafety. Key players are expanding their product portfolio through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical and biotechnology companies and by providing better services at a lower cost.

Growing Need for Safe Drug Development to Bring Tremendous Growth Opportunities for the Viral Clearance Service Market

The viral clearance service market is expected to gain good growth opportunities across the assessment period of 2018-2026 on the back of the rising demand for virus detection in specialty drugs and biological products. The growing demand for virus inactivation among a large number of drugs and biological products may bring extensive growth opportunities for the viral clearance service market.

  • Viral clearance services are utilized for the removal of bacteria or viruses that are present on drugs, production equipment, or biological products. The services include the testing of end-products and ensure consistent and safe development of biological products. All these aspects bode well for the growth of the viral clearance service market.
  • The rising numbers of diseases and disorders around the world have prompted many pharmaceutical companies to launch novel drugs and medicines that treat the conditions or disorders at a faster pace. The growing drug production levels may bring extensive growth prospects for the viral clearance service market.
  • Research and development activities have a large role in the growth of the viral clearance service market. The players in the viral clearance service market invest in these activities for exploring insights that help in adding more features to the services. These features eventually help in boosting the growth prospects of the viral clearance service market.
  • Strategic collaborations are also playing a crucial role in the growth of the viral clearance service market. The players indulge in mergers, acquisitions, joint ventures, and partnerships for strengthening their foothold in the viral clearance service market, ultimately increasing the growth rate of the viral clearance service market.
  • The COVID-19 pandemic has a minimal effect on the growth of the viral clearance service market. The services and production related to the healthcare sector were exempted from the strict lockdown restrictions, which served as a relief for the players in the viral clearance service market.

The global viral clearance service market has been segmented as follows:

by Application

  • Recombinant Proteins
  • Tissue and Blood Derived Products
  • Vaccines
  • Others

by Method

  • Viral Removal
  • Viral Inactivation
    • Chemical
    • Radiation
    • Other

by End-user

  • Biopharmaceuticals
  • Contract Research Organizations
  • Academic Research Institutes
  • Other End-users

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology
         2.1. Assumptions
         2.2. Research Methodology

    3. Executive Summary : Global Viral Clearance Service
         3.1.Global Viral Clearance Service Market Value (US$ Mn) and Distribution, by Geography, 2017 and 2026
         3.2. Global Viral Clearance Service Market Snapshot, 2017
         3.3. Global Viral Clearance Service Market: Opportunity Map

    4. Market Overview
         4.1. Introduction
                4.1.1. Application Definition
                4.1.2. Industry Evolution / Developments
         4.2. Overview
         4.3. Market Dynamics
                4.3.1. Drivers
                         4.3.1.1. Increased outsourcing of viral clearance testing studies
                         4.3.1.2. Rise in R&D expenditure
                         4.3.1.3. Rise in focus on early clearance of virus in biologics
                         4.3.1.4. Increased burden of regulatory requirements
                         4.3.1.5. Technological advancements
                         4.3.1.6. Growing economies of the world
                4.3.2. Restraints
                         4.3.2.1. Reduction of preclinical outsourcing budget by some of the large pharma companies
                         4.3.2.2. High cost and complexity involved in the development and approval of biologics and biosimilars
                4.3.3. Opportunities
         4.4. Global Viral Clearance Service Market Analysis and Forecast, 2016–2026
                4.4.1. Global Viral Clearance Service Market Value (US$ Mn) Forecast
         4.5. Porter’s Five Force Analysis

    5. Market Outlook
         5.1. Regulatory Scenario by Region/globally
         5.2. Key Mergers & Acquisitions
         5.3. Technological Advancements
         5.4. Key Market Trends
         5.5. Competitive Landscape Analysis (based on strategic developments of players)
         5.6. Future Prospects Assessment

    6. Global Viral Clearance Service Market Analysis and Forecast, by Application
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Global Viral Clearance Service Market Value Forecast, by Application, 2016–2026
                6.3.1. Recombinant Proteins
                6.3.2. Tissue and Blood Derived Products
                6.3.3. Vaccines
                6.3.4. Others
         6.4. Global Viral Clearance Service Market Attractiveness, by Application

    7. Global Viral Clearance Service Analysis and Forecast, by Method
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Global Viral Clearance Service Market Value Forecast, by Method, 2016–2026
                7.3.1. Viral Removal
                7.3.2. Viral Inactivation
                         7.3.2.1. Chemical
                         7.3.2.2. Radiation
                         7.3.2.3. Other
         7.4. Global Viral Clearance Service Market Attractiveness, by Method

    8. Global Viral Clearance Service Analysis and Forecast, by End-user
         8.1. Introduction & Definition
         8.2. Key Findings / Developments
         8.3. Global Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
                8.3.1. Biopharmaceuticals
                8.3.2. Contract Research Organizations
                8.3.3. Academic Research Institutes
                8.3.4. Other End-users
         8.4. Global Viral Clearance Service Market Attractiveness by End-user

    9. Global Viral Clearance Service Analysis and Forecast, by Region
         9.1. Key Findings
         9.2. Global Viral Clearance Service Market Value Forecast, by Region
                9.2.1. North America
                9.2.2. Europe
                9.2.3. Asia Pacific
                9.2.4. Latin America
                9.2.5. Middle East & Africa
         9.3. Global Viral Clearance Service Market Attractiveness, by Region

    10. North America Viral Clearance Service Analysis and Forecast
         10.1. Introduction
                10.1.1. Key Findings
         10.2. North America Viral Clearance Service Market Value Forecast, by Application, 2016–2026
                10.2.1. Recombinant Proteins
                10.2.2. Tissue and Blood Derived Products
                10.2.3. Vaccines
                10.2.4. Others
         10.3. North America Viral Clearance Service Market Value Forecast, by Method, 2016–2026
                10.3.1. Viral Removal
                10.3.2. Viral Inactivation
                         10.3.2.1. Chemical
                         10.3.2.2. Radiation
                         10.3.2.3. Other
         10.4. North America Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
                10.4.1. Biopharmaceuticals
                10.4.2. Contract Research Organizations
                10.4.3. Academic Research Institutes
                10.4.4. Other End-users
         10.5. North America Viral Clearance Service Market Value Forecast, by Country, 2016–2026
                10.5.1. U.S.
                10.5.2. Canada
         10.6. North America Viral Clearance Service Market Attractiveness Analysis
                10.6.1. By Application
                10.6.2. By Method
                10.6.3. By End-user
                10.6.4. By Country

    11. Europe Viral Clearance Service Analysis and Forecast
         11.1.Introduction
                11.1.1. Key Findings
         11.2. Europe Viral Clearance Service Market Value Forecast, by Application, 2016–2026
                11.2.1. Recombinant Proteins
                11.2.2. Tissue and Blood Derived Products
                11.2.3. Vaccines
                11.2.4. Others
         11.3. Europe Viral Clearance Service Market Value Forecast, by Method, 2016–2026
                11.3.1. Viral Removal
                11.3.2. Viral Inactivation
                         11.3.2.1. Chemical
                         11.3.2.2. Radiation
                         11.3.2.3. Other
         11.4. Europe Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
                11.4.1. Biopharmaceuticals
                11.4.2. Contract Research Organizations
                11.4.3. Academic Research Institutes
                11.4.4. Other End-users
         11.5. Europe Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
                11.5.1. Germany
                11.5.2. U.K.
                11.5.3. France
                11.5.4. Spain
                11.5.5. Italy
                11.5.6. Rest of Europe
         11.6. Europe Viral Clearance Service Market Attractiveness Analysis
                11.6.1. By Application
                11.6.2. By Method
                11.6.3. By End-user
                11.6.4. By Country/Sub-region

    12. Asia Pacific Viral Clearance Service Analysis and Forecast
         12.1.Introduction
                12.1.1. Key Findings
         12.2. Asia Pacific Viral Clearance Service Market Value Forecast, by Application, 2016–2026
                12.2.1. Recombinant Proteins
                12.2.2. Tissue and Blood Derived Products
                12.2.3. Vaccines
                12.2.4. Others
         12.3. Asia Pacific Viral Clearance Service Market Value Forecast, by Method, 2016–2026
                12.3.1. Viral Removal
                12.3.2. Viral Inactivation
                         12.3.2.1. Chemical
                         12.3.2.2. Radiation
                         12.3.2.3. Other
         12.4. Asia Pacific Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
                12.4.1. Biopharmaceuticals
                12.4.2. Contract Research Organizations
                12.4.3. Academic Research Institutes
                12.4.4. Other End-users
         12.5. Asia Pacific Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
                12.5.1. China
                12.5.2. Japan
                12.5.3. India
                12.5.4. Australia & New Zealand
                12.5.5. Rest of Asia Pacific
         12.6. Asia Pacific Viral Clearance Service Market Attractiveness Analysis
                12.6.1. By Application
                12.6.2. By Method
                12.6.3. By End-user
                12.6.4. By Country/Sub-region

    13. Latin America Viral Clearance Service Analysis and Forecast
         13.1.Introduction
                13.1.1. Key Findings
         13.2. Latin America Viral Clearance Service Market Value Forecast, by Application, 2016–2026
                13.2.1. Recombinant Proteins
                13.2.2. Tissue and Blood Derived Products
                13.2.3. Vaccines
                13.2.4. Others
         13.3. Latin America Viral Clearance Service Market Value Forecast, by Method, 2016–2026
                13.3.1. Viral Removal
                13.3.2. Viral Inactivation
                         13.3.2.1. Chemical
                         13.3.2.2. Radiation
                         13.3.2.3. Other
         13.4. Latin America Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
                13.4.1. Biopharmaceuticals
                13.4.2. Contract Research Organizations
                13.4.3. Academic Research Institutes
                13.4.4. Other End-users
         13.5. Latin America Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
                13.5.1. Brazil
                13.5.2. Mexico
                13.5.3. Rest of Latin America
         13.6. Latin America Viral Clearance Service Market Attractiveness Analysis
                13.6.1. By Application
                13.6.2. By Method
                13.6.3. By End-user
                13.6.4. By Country/Sub-region

    14. Middle East & Africa Viral Clearance Service Analysis and Forecast
         14.1.Introduction
                14.1.1. Key Findings
         14.2. Middle East & Africa Viral Clearance Service Market Value Forecast, by Application, 2016–2026
                14.2.1. Recombinant Proteins
                14.2.2. Tissue and Blood Derived Products
                14.2.3. Vaccines
                14.2.4. Others
         14.3. Middle East & Africa Viral Clearance Service Market Value Forecast, by Method, 2016–2026
                14.3.1. Viral Removal
                14.3.2. Viral Inactivation
                         14.3.2.1. Chemical
                         14.3.2.2. Radiation
                         14.3.2.3. Other
         14.4. Middle East & Africa Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
                14.4.1. Biopharmaceuticals
                14.4.2. Contract Research Organizations
                14.4.3. Academic Research Institutes
                14.4.4. Other End-users
         14.5. Middle East & Africa Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
                14.5.1. GCC Countries
                14.5.2. South Africa
                14.5.3. Rest of Middle East & Africa
         14.6. Middle East & Africa Viral Clearance Service Market Attractiveness Analysis
                14.6.1. By Application
                14.6.2. By Method
                14.6.3. By End-user
                14.6.4. By Country/Sub-region

    15. Competition Landscape
         15.1. Global Viral Clearance Service Market Player – Competition Matrix (by Tier and Size of companies)
         15.2. Global Viral Clearance Service Market Share Analysis, by Company (2017)
         15.3. Competitive Business Strategies
         15.4. Company Profiles
                15.4.1. Texcell
                         15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.4.1.2. Company Financials
                         15.4.1.3. Growth Strategies
                         15.4.1.4. Recent Events
                         15.4.1.5. SWOT Analysis
                15.4.2. Eurofins Scientific SE
                         15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.4.2.2. Company Financials
                         15.4.2.3. Growth Strategies
                         15.4.2.4. Recent Events
                         15.4.2.5. SWOT Analysis
                15.4.3. Charles River Laboratories International, Inc.
                         15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.4.3.2. Company Financials
                         15.4.3.3. Growth Strategies
                         15.4.3.4. Recent Events
                         15.4.3.5. SWOT Analysis
                15.4.4. Merck KGaA (BioReliance)
                         15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.4.4.2. Company Financials
                         15.4.4.3. Growth Strategies
                         15.4.4.4. Recent Events
                         15.4.4.5. SWOT Analysis
                15.4.5. WuXi AppTec
                         15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.4.5.2. Company Financials
                         15.4.5.3. Growth Strategies
                         15.4.5.4. Recent Events
                         15.4.5.5. SWOT Analysis
                15.4.6. Clean Cells
                         15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.4.6.2. Company Financials
                         15.4.6.3. Growth Strategies
                         15.4.6.4. Recent Events
                         15.4.6.5. SWOT Analysis
                15.4.7. Vironova Biosafety
                         15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                         15.4.7.2. Company Financials
                         15.4.7.3. Growth Strategies
                         15.4.7.4. Recent Events
                         15.4.7.5. SWOT Analysis

    List of Tables

    Table 01: Global Viral Clearance Service Market Value (US$ Mn) Forecast, 2016–2026
    Table 02: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 03: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
    Table 04: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 05: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Region, 2016–2026
    Table 06: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Country, 2016–2026
    Table 07: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 08: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
    Table 09: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
    Table 10: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 11: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 12: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 13: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
    Table 14: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
    Table 15: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 16: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 17: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 18: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
    Table 19: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
    Table 20: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 21: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 22: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 23: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
    Table 24: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
    Table 25: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 26: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 27: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 28: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
    Table 29: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
    Table 30: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 31: Competition Matrix

    List of Figures

    Figure 01: Global Viral Clearance Service Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
    Figure 02: Global Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 03: Global Viral Clearance Service Market Value Share, by Application, 2017 and 2026
    Figure 04: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Recombinant Proteins, 2016–2026
    Figure 05: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Tissue and Blood Derived Products, 2016–2026
    Figure 06: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2026
    Figure 07: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
    Figure 08: Global Viral Clearance Service Market Attractiveness Analysis, by Application, 2018–2026
    Figure 09: Global Viral Clearance Service Market Value Share, by Method, 2017 and 2026
    Figure 10: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Viral Removal , 2016–2026
    Figure 11: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Viral Inactivation, 2016–2026
    Figure 12: Global Viral Clearance Service Market Attractiveness Analysis, by Method, 2018–2026
    Figure 13: Global Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
    Figure 14: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Biopharmaceuticals, 2016–2026
    Figure 15: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016–2026
    Figure 16: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Academic Research Institutes, 2016–2026
    Figure 17: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Other End-users, 2016–2026
    Figure 18: Global Viral Clearance Service Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 19: Global Viral Clearance Service Market Value Share, by Region, 2017 and 2026
    Figure 20: Global Viral Clearance Service Market Attractiveness Analysis, by Region, 2018–2026
    Figure 21: North America Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 22: North America Viral Clearance Service Market Value Share, by Country, 2017 and 2026
    Figure 23: North America Viral Clearance Service Market Attractiveness, by Country, 2018–2026
    Figure 24: North America Viral Clearance Service Market Value Share, by Application, 2017 and 2026
    Figure 25: North America Viral Clearance Service Market Attractiveness, by Application, 2018–2026
    Figure 26: North America Viral Clearance Service Market Value Share, by Method, 2017 and 2026
    Figure 27: North America Viral Clearance Service Market Attractiveness, by Method, 2018–2026
    Figure 28: North America Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
    Figure 29: North America Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
    Figure 30: Europe Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 31: Europe Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 32: Europe Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 33: Europe Viral Clearance Service Market Value Share, by Application, 2017 and 2026
    Figure 34: Europe Viral Clearance Service Market Attractiveness, by Application, 2018–2026
    Figure 35: Europe Viral Clearance Service Market Value Share, by Method, 2017 and 2026
    Figure 36: Europe Viral Clearance Service Market Attractiveness, by Method, 2018–2026
    Figure 37: Europe Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
    Figure 38: Europe Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
    Figure 39: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 40: Asia Pacific Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 41: Asia Pacific Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 42: Asia Pacific Viral Clearance Service Market Value Share, by Application, 2017 and 2026
    Figure 43: Asia Pacific Viral Clearance Service Market Attractiveness, by Application, 2018–2026
    Figure 44: Asia Pacific Viral Clearance Service Market Value Share, by Method, 2017 and 2026
    Figure 45: Asia Pacific Viral Clearance Service Market Attractiveness, by Method, 2018–2026
    Figure 46: Asia Pacific Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
    Figure 47: Asia Pacific Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
    Figure 48: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 49: Latin America Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 50: Latin America Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 51: Latin America Viral Clearance Service Market Value Share, by Application, 2017 and 2026
    Figure 52: Latin America Viral Clearance Service Market Attractiveness, by Application, 2018–2026
    Figure 53: Latin America Viral Clearance Service Market Value Share, by Method, 2017 and 2026
    Figure 54: Latin America Viral Clearance Service Market Attractiveness, by Method, 2018–2026
    Figure 55: Latin America Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
    Figure 56: Latin America Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
    Figure 57: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 58: Middle East & Africa Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
    Figure 59: Middle East & Africa Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 60: Middle East & Africa Viral Clearance Service Market Value Share, by Application, 2017 and 2026
    Figure 61: Middle East & Africa Viral Clearance Service Market Attractiveness, by Application, 2018–2026
    Figure 62: Middle East & Africa Viral Clearance Service Market Value Share, by Method, 2017 and 2026
    Figure 63: Middle East & Africa Viral Clearance Service Market Attractiveness, by Method, 2018–2026
    Figure 64: Middle East & Africa Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
    Figure 65: Middle East & Africa Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
    Figure 66: Competitive Business Strategies
    Figure 67: Texcell SWOT
    Figure 68: Eurofins Scientific SE SWOT
    Figure 69: Charles River Laboratories International, Inc. SWOT
    Figure 70: Merck KGaA (BioReliance) SWOT
    Figure 66: WuXi AppTec SWOT
    Figure 72: Clean Cells SWOT
    Figure 73: Vironova Biosafety SWOT

Copyright © Transparency Market Research, Inc. All Rights reserved